FDFlorence Dzierszinski

Florence Dzierszinski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Florence Dzierszinski has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • David S. Roos

    Department of Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA

    2 shared publications
  • Amit Bahl

    Genomics and Computational Biology, University of Pennsylvania, Philadelphia PA 19104, USA

    1 shared publication
  • C. A. Hunter

    Department of Pathobiology, University of Pennsylvania, Philadelphia, USA

    1 shared publication
  • Christopher A. Hunter

    Departments of Biology,1 Pathobiology,2 Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,3 Department of Microbiology, Montana State University, Bozeman, Montana 597174

    1 shared publication
  • David F. LaRosa

    Departments of Biology,1 Pathobiology,2 Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,3 Department of Microbiology, Montana State University, Bozeman, Montana 597174

    1 shared publication
  • David Kulp

    Department of Computer Science, University of Massachusetts, Amherst MA, 01003, USA

    1 shared publication

Latest Publications

  • Open Access

    A novel multifunctional oligonucleotide microarray for Toxoplasma gondii

    by Amit Bahl, Paul H Davis, Michael Behnke, Florence Dzierszinski, Manjunatha Jagalur, Feng Chen, Dhanasekaran Shanmugam, Michael W White, David Kulp, David S Roos

    Background: Microarrays are invaluable tools for genome interrogation, SNP detection, and expression analysis, among other applications. Such broad capabilities would be of value to many pathogen research communities, although the development and use of genome-scale microarrays is often a costly undertaking. Therefore, effective methods for reducing unnecessary probes while maintaining or expanding functionality would be relevant to many investigators. Results: Taking advantage of available genome sequences and annotation for Toxoplasma gondii (a pathogenic parasite responsible for illness in immunocompromised individuals) and Plasmodium falciparum (a related parasite responsible for severe human malaria), we designed a single oligonucleotide microarray capable of supporting a wide range of applications at relatively low cost, including genome-wide expression profiling for Toxoplasma, and single-nucleotide polymorphism (SNP)-based genotyping of both T. gondii and P. falciparum. Expression profiling of the three clonotypic lineages dominating T. gondii populations in North America and Europe provides a first comprehensive view of the parasite transcriptome, revealing that ~49% of all annotated genes are expressed in parasite tachyzoites (the acutely lytic stage responsible for pathogenesis) and 26% of genes are differentially expressed among strains. A novel design utilizing few probes provided high confidence genotyping, used here to resolve recombination points in the clonal progeny of sexual crosses. Recent sequencing of additional T. gondii isolates identifies >620 K new SNPs, including ~11 K that intersect with expression profiling probes, yielding additional markers for genotyping studies, and further validating the utility of a combined expression profiling/genotyping array design. Additional applications facilitating SNP and transcript discovery, alternative statistical methods for quantifying gene expression, etc. are also pursued at pilot scale to inform future array designs. Conclusions: In addition to providing an initial global view of the T. gondii transcriptome across major lineages and permitting detailed resolution of recombination points in a historical sexual cross, the multifunctional nature of this array also allowed opportunities to exploit probes for purposes beyond their intended use, enhancing analyses. This array is in widespread use by the T. gondii research community, and several aspects of the design strategy are likely to be useful for other pathogens.


  • Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii

    by F. S. Dzierszinski, C. A. Hunter

    Studying in vivo biology and the host immune response to Toxoplasma gondii has yielded many insights into the pathogenesis of this parasitic organism. It is recognized that this infection in immune competent hosts elicits a strong Th1-type response, which is characterized by the generation of parasite-specific CD4(+) and CD8(+) T cells that produce IFN-gamma and provide protective immunity. One of the problems associated with studying resistance to Toxoplasma has been the lack of reagents to track parasite-specific T cell responses with a high degree of specificity. To overcome this difficulty, it is possible to use a combination of transgenic parasites that are engineered to express well-characterized heterologous reporters or antigens, and T cell hybridomas or naïve T cells that express a T cell receptor specific for the processed peptide. These approaches have provided new insights into parasite dissemination, antigen presentation, as well as immune regulation.


  • Presentation ofToxoplasma gondiiAntigens via the Endogenous Major Histocompatibility Complex Class I Pathway in Nonprofessional and Professional Antigen-Presenting Cells

    by Florence Dzierszinski, Marion Pepper, Jason S. Stumhofer, David F. LaRosa, Emma H. Wilson, Laurence A. Turka, Sandra K. Halonen, Christopher A. Hunter, David S. Roos

    Challenge with the intracellular protozoan parasiteToxoplasma gondiiinduces a potent CD8+T-cell response that is required for resistance to infection, but many questions remain about the factors that regulate the presentation of major histocompatibility complex class I (MHC-I)-restricted parasite antigens and about the role of professional and nonprofessional accessory cells. In order to address these issues, transgenic parasites expressing ovalbumin (OVA), reagents that track OVA/MHC-I presentation, and OVA-specific CD8+T cells were exploited to compare the abilities of different infected cell types to stimulate CD8+T cells and to define the factors that contribute to antigen processing. These studies reveal that a variety of infected cell types, including hematopoietic and nonhematopoietic cells, are capable of activating an OVA-specific CD8+T-cell hybridoma, and that this phenomenon is dependent on the transporter associated with antigen processing and requires liveT. gondii. Several experimental approaches indicate that T-cell activation is a consequence of direct presentation by infected host cells rather than cross-presentation. Surprisingly, nonprofessional antigen-presenting cells (APCs) were at least as efficient as dendritic cells at activating this MHC-I-restricted response. Studies to assess whether these cells are involved in initiation of the CD8+T-cell response toT. gondiiin vivo show that chimeric mice expressing MHC-I only in nonhematopoietic compartments are able to activate OVA-specific CD8+T cells upon challenge. These findings associate nonprofessional APCs with the initial activation of CD8+T cells during toxoplasmosis.